Recellularized bovine pericardium with autologous mesenchymal stem cells reduces immune activation
Sign Up to like & getrecommendations! Published in 2022 at "Xenotransplantation"
DOI: 10.1111/xen.12774
Abstract: Current bioprosthetic heart valve replacement options are limited by structural valvular deterioration (SVD) due to an immune response to the xenogenic scaffold. Autologous mesenchymal stem cell (MSC) recellularization is a method of concealing xenogenic scaffolds,… read more here.
Keywords: pericardium; autologous mesenchymal; mesenchymal stem; recellularized bovine ... See more keywords